One case report presented severe cardiomyopathy in anti-SRP and anti-MDA-5 IMNM, with progression after immunosuppressive therapy, despite improvement of the clinical myopathy, which needed heart transplantation, supporting the data that this subset of antibodies is a negative prognostic factor [43,44]. The gene discussed is UCN2; the disease is myopathy.